LBSCX
Price
$34.25
Change
+$0.10 (+0.29%)
Updated
Jul 25 closing price
Net Assets
43.97B
RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.07B
Interact to see
Advertisement

LBSCX vs RMFEX

Header iconLBSCX vs RMFEX Comparison
Open Charts LBSCX vs RMFEXBanner chart's image
Columbia Dividend Income C
Price$34.25
Change+$0.10 (+0.29%)
VolumeN/A
Net Assets43.97B
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.07B
LBSCX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LBSCX vs. RMFEX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LBSCX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 110B vs. LBSCX (44B). RMFEX pays higher dividends than LBSCX: RMFEX (1.53) vs LBSCX (0.76). LBSCX was incepted earlier than RMFEX: LBSCX (23 years) vs RMFEX (23 years). LBSCX (1.65) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. LBSCX (14.00). RMFEX has a lower initial minimum investment than LBSCX: RMFEX (250) vs LBSCX (2000). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. LBSCX (8.35). RMFEX (62.99) and LBSCX (61.37) have equivalent 5 years return.
LBSCXRMFEXLBSCX / RMFEX
Total Expense Ratio1.650.62266%
Annual Report Gross Expense Ratio1.650.62266%
Fund Existence23 years23 years-
Gain YTD8.03211.52770%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets44B110B40%
Annual Yield % from dividends0.761.5349%
Returns for 1 year8.3511.7471%
Returns for 3 years29.3932.0892%
Returns for 5 years61.3762.9997%
Returns for 10 years98.0988.96110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited